Feprazone
CAS No. 30748-29-9
Feprazone ( DA-2370; DA 2370; DA2370; Prenazone )
产品货号. M28561 CAS No. 30748-29-9
Feprazone possesses anti-inflammatory and antiadipogenic properties. Feprazone can be used in studies about the treatment of joint and muscular pain.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥405 | 有现货 |
|
10MG | ¥591 | 有现货 |
|
25MG | ¥1029 | 有现货 |
|
50MG | ¥1515 | 有现货 |
|
100MG | ¥2155 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Feprazone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Feprazone possesses anti-inflammatory and antiadipogenic properties. Feprazone can be used in studies about the treatment of joint and muscular pain.
-
产品描述Feprazone possesses anti-inflammatory and antiadipogenic properties. Feprazone can be used in studies about the treatment of joint and muscular pain.(In Vitro):Lipid accumulation, elevated production of triglycerides, the release of glycerol, upregulated SREBP-1C, FABP4, PPAR-γ, and C/EBP-α and downregulated ATGL and AQP-7 in the 3 T3-L1 adipocytes induced by the adipocyte differentiation cocktail medium were significantly reversed by treatment with Feprazone(30 and 60 μM).
-
同义词DA-2370; DA 2370; DA2370; Prenazone
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number30748-29-9
-
分子量320.4
-
分子式C20H20N2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(C)=CCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Xu J, et al. Anesthetics disrupt growth cone guidance cue sensing through actions on the GABAA α2 receptor mediated by the immature chloride gradient. Neurotoxicol Teratol. 2019 Jul-Aug;74:106812.
产品手册
关联产品
-
C14TKL-1 TFA
Endogenous human tachykinin-like peptide and potent agonist for NK1 receptors (EC50 = 1 nM).
-
Yoda 1
Yoda1 is a Piezo1 ion channel agonist (EC50s = 17.1 and 26.6 μM for murine and human Piezo1-transfected HEK293T cells respectively).
-
Sibiricose A4
Sibiricose A4 is a natural product for research related to life sciences.